U.S. Markets closed

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.915+0.005 (+0.549%)
At close: 4:10PM AEST

Starpharma Holdings Limited

4-6 Southampton Crescent
Abbotsford, VIC 3067
Australia
61 3 8532 2700
http://www.starpharma.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA, GAICDChief Exec. Officer, Managing Director and Exec. DirectorN/AN/A54
Mr. Nigel J. Baade B.Com, CPA, Grad. Dip. ArtsChief Financial Officer and Company Sec.N/AN/AN/A
Dr. A. Eglezos BSc(Hons),Ph.D., MBAVP of Bus. Devel.N/AN/AN/A
Dr. Jeremy R. Paull BSc (Hons), Ph.D.VP of Devel. and Regulatory AffairsN/AN/AN/A
Dr. David J. Owen BSc(Hons) Ph.D.VP of ResearchN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of VivaGel, an antimicrobial agent that is in Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for prevention of sexual transmitted infections. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel, which is in Phase I clinical trial for breast, prostate, lung, and ovarian tumor; and agrochemicals. Starpharma Holdings Limited was founded in 1996 and is headquartered in Abbotsford, Australia.

Corporate Governance

Starpharma Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.